The ResMed-Samsung Partnership: Revolutionizing Sleep Health
Discover how two industry giants are transforming sleep apnea detection and treatment through innovative technology integration. This groundbreaking collaboration connects Samsung's consumer wearables with ResMed's medical expertise to create a seamless journey from detection to treatment.
Keep scrolling to learn how this partnership is changing lives and reshaping the future of sleep health technology.
Timeline: Building a Sleep Health Alliance
1
2019: Identifying the Problem
ResMed funds landmark study revealing nearly 1 billion people worldwide have obstructive sleep apnea (OSA), highlighting a massive undiagnosed population.
2
2023: Laying Groundwork
Samsung receives approval in South Korea for watch-based sleep apnea detection algorithm while ResMed enhances its cloud-connected ecosystem.
3
January 2024: CES Showcase
ResMed's sleep therapy devices featured in Samsung's "massive" CES booth, demonstrating end-to-end solution from detection to treatment.
4
February 2024: FDA Authorization
Samsung's sleep apnea detection feature receives FDA authorization as first-of-its-kind consumer wearable for OSA risk screening.
The Partnership Continues to Evolve
1
September 2024: Digital Integration
ResMed updates myAir patient app to integrate with wearables including Samsung Galaxy Watch, allowing users to monitor CPAP therapy metrics at a glance.
2
Late 2024: Data Sharing Capabilities
ResMed introduces features to import sleep data from Google's Health Connect (which Samsung Health uses) into myAir, creating unified sleep health dashboard.
3
2025 and Beyond: Ongoing Collaboration
Samsung expands beyond detection into intervention and management of sleep health, while both companies work to make the journey from recognizing sleep issues to treatment more seamless.
This evolving partnership demonstrates both companies' commitment to improving sleep health through technological innovation and integration.
ResMed's Strategic Vision
Extending Beyond Clinical Realm
ResMed aims to reach consumers in their daily lives, using Samsung's popular devices to identify undiagnosed patients and guide them to appropriate care.
Increasing Patient Identification
CEO Mick Farrell notes consumer wearables detecting sleep issues are a "megatrend" that can increase the patient funnel for CPAP therapy.
Improving Treatment Adherence
By integrating with smartphones and watches, ResMed can boost engagement and long-term compliance with sleep apnea therapy.
Samsung's Strategic Goals
Market Differentiation
First FDA-cleared sleep apnea detection on a smartwatch sets Samsung apart from competitors, especially Apple, giving them a first-mover advantage.
Complete Health Solution
Partnership with ResMed helps close the loop from detection to treatment, keeping users engaged in the Samsung Health ecosystem.
Data and AI Development
Access to insights from millions of nights of sleep data improves Samsung's health algorithms and supports their goal of managing conditions through AI-driven insights.
Samsung's motto for Samsung Health is to create a "seamlessly connected ecosystem of personalized wellness experiences" - this partnership is key to that vision.
Key Areas of Collaboration
Sleep Tracking & Apnea Detection
Samsung developed technology to monitor sleep via smartwatch sensors and analyze data for patterns of OSA, while ResMed provides clinical insights and validation.
Health Data Integration
Two-way data flow between ResMed's therapy data and Samsung's health platforms creates a holistic view of sleep health for users.
Consumer Wellness
Joint research initiatives, educational content, and engagement tools keep users motivated to improve their sleep health.
Device Compatibility
ResMed ensures its software works seamlessly with Samsung devices, creating a native feel across the integrated ecosystem.
Products Born From Partnership
Galaxy Watch Sleep Apnea Monitoring
Samsung's Galaxy Watch now offers built-in sleep apnea risk detection, monitoring oxygen saturation and pulse during sleep to identify patterns suggestive of moderate or severe OSA.
myAir Smartwatch Integration
ResMed's myAir app now syncs with Samsung Galaxy Watches, allowing users to view their CPAP therapy metrics directly on their wrist with a simple glance.
Unified Sleep Data Dashboard
ResMed updated myAir to import sleep-tracking data from Samsung devices, creating a comprehensive view that combines CPAP therapy data with sleep stages and other health metrics.
Data Sharing & Privacy Safeguards
Standards-Based Approach
Rather than building a closed system, the partnership leverages Google's Health Connect as a neutral conduit to exchange data between ResMed and Samsung platforms.
User Control & Consent
All data sharing requires explicit user permission, with granular controls allowing users to decide exactly what information is shared between platforms.
Medical Data Protection
ResMed applies HIPAA-compliant measures to protect patient data, while Samsung secures health information per consumer privacy frameworks.
Secure Transfer Methods
Data transfers occur via encrypted channels, with both companies employing robust cybersecurity defenses to protect sensitive health information.
This careful approach allows the partnership to deliver a richer user experience without compromising privacy.
What Industry Leaders Are Saying
ResMed CEO Mick Farrell
"Samsung was touting their new Galaxy Watch's sleep apnea detection capability and illustrating the link between their Galaxy Watch ecosystem and ResMed's market-leading products for the treatment of sleep apnea."
ResMed CMO Dr. Carlos Nunez
"We know that digital wearables and other innovative technologies like AI can help consumers better understand their sleep habits and create a personalized pathway to better rest."
Samsung's Dr. Hon Pak
"Together, we aim to move beyond screening to also provide more meaningful daily support that helps people better understand and manage their sleep health."
Impact on Patients & Consumers
Earlier Intervention
Users can discover potential sleep apnea through their Galaxy Watch, leading to earlier diagnosis and treatment that improves overall health and potentially extends lives.
Improved Adherence
ResMed reports that patients active on the myAir platform use their CPAP about 1 hour longer per night on average, with 87% achieving clinically recommended adherence.
Seamless Experience
Integration transforms medical therapy into part of a wellness routine, with engaging interfaces that motivate users to stay consistent with treatment.
Market Transformation
New Care Paradigm
Creating a seamless journey from detection to treatment
Expanded Market Reach
Connecting with millions of potential patients
Industry Convergence
Blurring lines between consumer tech and medical devices
Data-Driven Innovation
Leveraging combined insights for better products
This partnership is reshaping how health technologies are developed and delivered, driving the entire sleep health field forward into a new era of connected care that benefits both patients and providers.
The Future of Connected Sleep Health
The ResMed-Samsung partnership represents a transformative approach to healthcare that combines clinical expertise with consumer technology. By creating a seamless pathway from detection to treatment, they're addressing the massive problem of undiagnosed sleep apnea while making therapy more engaging and effective.
As this collaboration continues to evolve, we can expect even deeper integration between consumer devices and medical solutions, more personalized AI-driven coaching, and ultimately better health outcomes for millions of people worldwide.
Did this overview of the ResMed-Samsung partnership surprise you? Tag someone who might benefit from learning about these sleep health innovations!